In line with this reasoning, it will be interesting to study whether NF‐κB inhibitors can down‐regulate MYB and inhibit the proliferation of CYLD‐defective cylindroma cells. The gene discussed is NFKB1; the disease is adnexal spiradenoma/cylindroma of a sweat gland.